Key facts
- Soleus Capital is a private equity firm based in Greenwich, Connecticut with 15 tracked portfolio companies.
- Notable positions include Neurona Therapeutics, Parabilis Medicines, Abcuro, Candid Therapeutics, Precision Neuroscience.
- Soleus Capital has 1 fund on record, raising $144 across the 1 that report a size.
- The team roster lists 6 people.
About Soleus Capital
Founded in 2018, Soleus Capital is a private equity firm based in Greenwich, Connecticut. The firm seeks to invest in companies operating in life sciences, including biotech, medtech, diagnostics, and genomics sectors. This firm is a Registered Investment Adviser (RIA).
Free account
See the whole book
- ·The book's top 25 — of 15 recorded positions
- ·Watchlist + alerts for Soleus Capital's activity
Create free account
No card required
Portfolio, priced
15 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Neurona Therapeutics | Drug Discovery | $1.1B | — | |
| Parabilis Medicines | Drug Discovery | $920.0M | — | |
| Abcuro | Drug Discovery | $700.0M | — | |
| Candid Therapeutics | Drug Discovery | $657.0M | — | |
| Precision Neuroscience | — | $529.0M | — | |
| Pillar Biosciences | — | $309.0M | — | |
| Mission Bio | — | $300.0M | — | |
| Artios | Drug Discovery | $260.3M | — | |
| Parse Biosciences | — | $225.0M | — | |
| Longeviti | — | $110.0M | — | |
| Variantyx | — | $98.0M | — | |
| Notal Vision | — | — | — | |
| Swift Health Systems | — | — | — | |
| AltruBio | Drug Discovery | — | — | |
| Star Therapeutics | Biotechnology | — | — |
Funds
1 recorded- Soleus Credit Opportunites Fund I2025$144
$144 raised across the 1 fund that report a size
Team
6 people on record — 6 with verified contacts
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked
- What companies does Soleus Capital invest in?
- Soleus Capital has 15 recorded portfolio companies, including Neurona Therapeutics, Parabilis Medicines, Abcuro, Candid Therapeutics.
- What is Soleus Capital's AUM?
- Soleus Capital manages approximately $2.3B in assets.